Aisling Capital Management LP

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 8, 2024
Value $
$231M
Signature - Title
Robert J. Wenzel - Chief Financial Officer
Location
489 5 Th Ave, 10 Th Floor, New York, NY
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 15 $231M +$1.39M -$2.24M -$854K BBIO, SNDX, VRNA, ELEV, NUVB 13F-HR 8/8/2024, 02:56 PM
Q1 2024 15 $294M +$2.17M -$51.2K +$2.12M BBIO, SNDX, VRNA, ELEV, BMEA 13F-HR 5/14/2024, 04:08 PM
Q4 2023 16 $335M -$829K -$829K BBIO, VRNA, SNDX, BMEA, CMPS 13F-HR 2/7/2024, 03:39 PM
Q3 2023 17 $243M +$7.97M -$762K +$7.2M BBIO, VRNA, SNDX, BMEA, CMPS 13F-HR 11/13/2023, 09:58 AM
Q2 2023 16 $204M +$974K +$974K BBIO, VRNA, SNDX, BMEA, GLUE 13F-HR 8/11/2023, 04:40 PM
Q1 2023 16 $208M -$6.37M -$6.37M BBIO, BMEA, VRNA, SNDX, GLUE 13F-HR 5/9/2023, 10:32 AM
Q4 2022 16 $151M -$3.15M -$3.15M BBIO, VRNA, SNDX, GLUE, ACRS 13F-HR 2/9/2023, 02:26 PM
Q3 2022 17 $151M -$1.34M -$1.34M BBIO, SNDX, VRNA, GLUE, ACRS 13F-HR 11/3/2022, 05:02 PM
Q2 2022 19 $140M -$834K -$834K BBIO, SNDX, GLUE, BMEA, ACRS 13F-HR 8/10/2022, 05:19 PM
Q1 2022 20 $185M -$2.11M -$2.11M BBIO, GLUE, SNDX, HRMY, NUVB 13F-HR 5/10/2022, 01:33 PM
Q4 2021 21 $283M -$10.1M -$10.1M BBIO, GLUE, SNDX, NUVB, ELEV 13F-HR 2/18/2022, 03:04 PM
Q3 2021 21 $501M $0 -$9.58M -$9.58M BBIO, GLUE, NUVB, HRMY, ELEV 13F-HR 11/12/2021, 09:57 AM
Q2 2021 21 $625M +$106M $0 +$106M BBIO, ELEV, GLUE, HRMY, NUVB 13F-HR 8/6/2021, 10:40 AM
Q1 2021 15 $556M +$157M -$150M +$7.16M BBIO, HRMY, NUVB, SNDX, SPRB 13F-HR 5/14/2021, 10:43 AM
Q4 2020 16 $582M +$29.3M -$4.16M +$25.1M BBIO, EIDX, HRMY, SPRB, SNDX Restatement 2/4/2021, 04:51 PM
Q3 2020 15 $313M +$43.4M -$11.4M +$32M BBIO, EIDX, HRMY, SNDX, AVRO 13F-HR 11/10/2020, 04:40 PM
Q2 2020 13 $262M +$5.92M +$5.92M BBIO, EIDX, AVRO, AGLE, SNDX 13F-HR 8/10/2020, 04:03 PM
Q1 2020 14 $230M +$15.9M +$15.9M BBIO, EIDX, AVRO, SNDX, BCEL 13F-HR 5/11/2020, 03:23 PM
Q4 2019 13 $261M +$1.05M +$1.05M BBIO, EIDX, AVRO, AGLE, BCEL 13F-HR 2/6/2020, 11:09 AM
Q3 2019 13 $192M +$3.15M +$3.15M BBIO, EIDX, AVRO, OBSVF, MRKR 13F-HR 11/13/2019, 11:06 AM
Q2 2019 14 $234M +$113M +$113M BBIO, EIDX, MRKR, OBSVF, AVRO Restatement 8/13/2019, 02:48 PM
Q1 2019 12 $131M +$10.6M -$2.54M +$8.03M EIDX, AVRO, OBSVF, BHVNXXXX, MRKR 13F-HR 5/20/2019, 05:24 PM
Q4 2018 12 $94.9M OBSVF, EIDX, AVRO, MRKR, BHVNXXXX 13F-HR 2/8/2019, 01:26 PM